Isolator
Closed Pre-Solicitation Posted
- Solicitation number
- 75F40124Q121770A
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Jamaica, New York 11433, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is seeking sources capable of providing one isolator on behalf of the New York Laboratory Medical Products (NYLMP). The isolator must be newly manufactured, compliant with FDA 21 CFR Part 11, and fitted with a decontamination system and other technical capabilities. The government requires a minimum one-year warranty, on-site training, preventative maintenance, and repair services. Interested contractors must respond with capability statements by August 25, 2024, but this is not a solicitation, and the government reserves the right to use the information provided for any purpose deemed necessary.
This opportunity is set aside for small businesses. The government has not identified any potential incumbents or current contractors. The value of the contract is not specified, but the agency is seeking to acquire one isolator to enhance and support sterility analysis processes within NYLMP. The contract term and any additional requirements are also not provided in the pre-solicitation notice.
Notice text
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) has issued this sources sought announcement on behalf of the New York Laboratory Medical Products (NYLMP) in order to determine if there are existing small business sources capable of providing one isolator.
Interested Contractors must respond with capability statements which are due by email to the point of contact listed below on or before August 25, 2024 by 10:00am (EST) at the Food and Drug Administration, Attn: Nina Montgomery, email nina.montgomery@fda.hhs.gov. Reference: 75F40124Q121770A.
Disclaimer and Important Notes
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre‐solicitation synopsis and solicitation may be published in sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation.
Files
| File | Type | Posted |
|---|---|---|
| Sources sought -121770A.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity